Toxta 100 Units
Pharmaceutical-grade Botulinum Toxin Type A for Precision Facial Contouring
Advanced Neurotoxin Formulation & Medical Grade Standard
Toxta utilizes purified Clostridium Botulinum Toxin A (CBFC26 strain) manufactured under strict cGMP conditions. Through patented purification processes achieving 99.5% toxin purity, the formulation demonstrates precise neuromuscular blocking activity with diffusion characteristics limited to 15-20mm from injection site. Clinical studies show 92% patient satisfaction in wrinkle reduction at 4 weeks post-treatment, with onset of action within 48-72 hours and peak effect at 14 days. The 100-unit vial maintains 98% potency when stored at recommended conditions.
Clinically Validated Benefits
Dynamic Wrinkle Reduction
Reduces glabellar lines by 82% and forehead lines by 78% at 30 days post-treatment
Precision Muscle Relaxation
Provides controlled chemodenervation lasting 3-4 months with predictable diffusion pattern
Hyperhidrosis Control
Reduces axillary sweating by 87% for 6-9 months per treatment cycle
Facial Symmetry
Corrects muscular asymmetries with 0.5-1 unit precision dosing capability
Pharmaceutical Specifications
- Active Substance: Botulinum Toxin Type A 100 units/vial
- Strain: Clostridium Botulinum CBFC26
- Production Standard: cGMP, ISO 13485 Certified
- Excipients: Human Serum Albumin 0.5mg, NaCl 0.9mg
- Storage: -5°C to -20°C protected from light
- Reconstitution: Use preservative-free 0.9% NaCl only
Treatment Areas
- Glabellar Lines: 20-30 units total dose
- Forehead Lines: 10-15 units in 4-6 injection points
- Crow’s Feet: 6-12 units per side
- Bunny Lines: 2-4 units per side
- Hyperhidrosis: 50 units per axilla
- Neck Bands: 10-20 units per band
Professional Administration Protocol
Reconstitution Guidelines
Reconstitute with 1-2.5ml preservative-free 0.9% NaCl (40-100 units/ml concentration). Gently rotate vial – do not shake. Use within 4 hours of reconstitution. Store at 2-8°C during clinical use.
Injection Technique
Use 30-32G needles for precise intramuscular delivery. Maintain 1-1.5cm spacing between injection points. Avoid blood vessels and superficial dermal layers. Apply ice pre-treatment to minimize bruising.
Post-Treatment Care
Patients should remain upright for 4 hours post-injection. Avoid rubbing treated areas for 24 hours. Exercise facial muscles hourly for first 4 hours to enhance toxin uptake. Full effects visible at 14 days.
Important Clinical Notice
Notice: Therapeutic outcomes may vary significantly between patients due to individual muscle mass, injection technique, and metabolic factors. All treatments must be administered by board-certified dermatologists or plastic surgeons with neurotoxin certification.
Contraindications include: neuromuscular disorders (myasthenia gravis, ALS), pregnancy/lactation, allergy to any component, and active skin infection at injection sites. Avoid concomitant use with aminoglycosides or other neuromuscular blockers. Effects typically last 3-4 months with gradual wearing off.
Reviews
There are no reviews yet.